U.S. Pharmacist


GPhA Applauds Approval of Patent Reform Act

By Staff


US Pharm. 2009;34(6)(Generic Drug Review suppl.):4.

The Generic Pharmaceutical Association (GPhA) praised Senator Patrick Leahy (D-VT) for his leadership following Senate Judiciary Committee approval of the Patent Reform Act of 2009. In a prepared statement, GPhA President and CEO Kathleen Jaeger said that approval of the Act "will protect and enhance the integrity of the patent process while also ensuring that Americans have access to affordable generic medicines. We are pleased that the legislation as passed by the Committee does not contain provisions that could have had the unintended consequences of erecting any barriers to the introduction of generic medicines that help consumers save money, particularly in these difficult economic times." She added that the GPhA, AARP, and other organizations strongly encouraged committee members to maintain a strong position on inequitable conduct.


U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students, other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Copyright © 2000 - 2015 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.